| Indira Vugdalic, PHARMD | |
|
385 W Main St, Avon, CT 06001-4357 | |
| (860) 674-0027 | |
| Not Available |
| Full Name | Indira Vugdalic |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 385 W Main St, Avon, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396144333 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PCT0013049 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Indira Vugdalic, PHARMD 276 Burnham Rd, Avon, CT 06001-2502 Ph: () - | Indira Vugdalic, PHARMD 385 W Main St, Avon, CT 06001-4357 Ph: (860) 674-0027 |
News Archive
Kindred Healthcare, Inc. today announced that it has successfully completed an amendment to its revolving credit agreement to increase the available credit capacity from $500 million to $600 million. In connection with the amendment, the Company agreed to a 50 basis points increase to the floating interest rate pricing levels under the Credit Agreement.
Research scientists from The Feinstein Institute for Medical Research and the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, NY, in conjunction with their colleagues at Rockefeller University in New York City, have developed a new understanding of how certain psychiatric diseases - those that involve uncontrollable reactions to stimuli such as the high and low experiences attributed to bi-polar disorder, the impulsivity of an individual suffering from attention deficit hyperactivity disorder, and even suicidality - manifest and potentially can be treated. These findings were published today in Proceedings of the National Academy of Sciences.
Patients suffering with heart failure are more likely to die if they have high levels of a bone hormone called osteoprotegerin (OPG).
Patients with schizophrenia who have a history of suicide attempts show a different pattern of temperament and character traits compared with their nonsuicidal counterparts, say Turkish researchers.
Amarillo Biosciences, Inc. today announced that it has agreed to a strategic partnership with Intas Pharmaceuticals Limited (Intas), one of the top 20 pharmaceutical companies in India, whereby Intas will sponsor clinical trials of ABI's orally administered interferon-alpha lozenges in order to combat influenza. Intas will pay ABI a royalty on net sales after marketing approval is obtained in India.
› Verified 3 days ago
Beatrice Fritz, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 255 W Main St, Avon, CT 06001 Phone: 860-409-0406 | |
Mr. Thomas Edward Buckley, RPH, MPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 209 New Rd, Avon, CT 06001 Phone: 860-693-9206 Fax: 860-693-4052 | |
Suzanne L Melanson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 358 W Main St, Avon, CT 06001 Phone: 860-678-8605 | |
Virginia Lee Hennessey, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 255 W Main St, Avon, CT 06001 Phone: 860-409-0409 Fax: 860-409-0410 | |
Dr. Artemis Stamos, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 255 W Main St, Avon, CT 06001 Phone: 860-409-0406 | |
Andrea Huntley, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 358 W Main St, Avon, CT 06001 Phone: 860-678-8605 |